ÑÇÐÇÓÎÏ·¹ÙÍø-www.yaxin868.com

ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾Ï³´²¹Ù·½ÍøÕ¾½ñÌìÊÇ£º2025-06-24Çл»³ÇÊÐ[È«¹ú]-ÍøÕ¾µØÍ¼
ÍÆ¼ö²úÆ· :
ÍÆ¼öÐÂÎÅ
¼¼ÊõÎÄÕµ±Ç°Î»ÖÃ:¼¼ÊõÎÄÕÂ>

4ÖÖ²»Í¬»ùÒòÑÇÐÍÖíÔ²»·²¡¶¾2ÐÍ·Ö×Ó¿Ë¡¶¾ÖêµÄ¹¹½¨¼°ÆäÓ¦ÓõÄÖÆ×÷·½·¨

ʱ¼ä:2025-06-24    ×÷Õß: ¹ÜÀíÔ±

רÀûÃû³Æ£º4ÖÖ²»Í¬»ùÒòÑÇÐÍÖíÔ²»·²¡¶¾2ÐÍ·Ö×Ó¿Ë¡¶¾ÖêµÄ¹¹½¨¼°ÆäÓ¦ÓõÄÖÆ×÷·½·¨
¼¼ÊõÁìÓò£º
±¾·¢Ã÷Éæ¼°ÖØ×é¶¾Ö꣬ÓÈÆäÉæ¼°ÖíÔ²»·²¡¶¾2Ðͱê¼Ç¶¾Öê¼°Æä¹¹½¨·½·¨£¬±¾·¢Ã÷ »¹Éæ¼°ÉÏÊö¶¾ÖêµÄÓ¦Óã¬ÊôÓÚÖØ×éÖíÔ²»·²¡¶¾2ÐͶ¾ÖêÁìÓò¡£
±³¾°¼¼Êõ£º
ÖíÔ²»·²¡¶¾2ÐÍ(Porcine circovirus type 2£¬PCV2)Ö÷ÒªÒýÆð¶ÏÄÌ×ÐÖí¶à ϵͳ˥½ß×ÛºÏÕ÷(Postweaning multisystemic wastingsyndrome, PMWS),¸Ã²¡ÓÚ 1997 ÄêÔÚ¼ÓÄôóÊ״α»Ö¤Êµ£¬ÃÀ¹ú¡¢·¨¹ú¡¢ÈÕ±¾¡¢º«¹úµÈÏà¼Ì·¢ÏÖÖíȺÖдæÔÚPMWS (Mankertz A, DomingoM, Folch J M, et al. Characterization of PCV2 isolates from Spain, Germany and France[J]. Virus Research,2000,66(1) :65-77 £»Ellis J, Clark E, Haines D, et al. Porcine circovirus-2 and concurrent infections inthe field[J]. Veterinary Microbiology,2004,98 :159-163 £»Wellenberg GJ, Stockhofe Z N, Boersma W J, et al. The presence of co-infections inpigs with clinical signs of PMWS in the Netherlands :case_control study[J]. Research Veterinary Science,2004, 77¢Æ177-184.)¡£³ýPMWSϦ²·£¬ÖíÆ¤Ñ×ÓëÉö²¡×ÛºÏÕ÷£¬ÖíºôÎüµÀ×ÛºÏÕ÷£¬·±Ö³Õϰ­£¬Èâ Ñ¿Ö×ÐÔ³¦Ñ×£¬»µËÀÐÔÁܰÍÏÙÑ×£¬Éø³öÐÔÆ¤Ñ×£¬ÏÈÌìÐÔÕð²üµÈÒ²ÓëPCV2¸ÐȾÓйØ¡£²¡¶¾ ¸ÐȾµÄÖ²¡ÐÔÖ÷ÒªÓë»úÌåÃâÒßϵͳÏ໥×÷ÓÃÓйأ¬PCV2¸ÐȾ¶ÔÖíÃâÒß¹¦ÄܵÄÓ°ÏìÒÔ¼° ÓÉ´ËÒýÆðµÄÃâÒßÒÖÖÆµÈÎÊÌⱸÊܹúÄÚÍâѧÕß¹Ø×¢£¬ÒѳÉΪ½üÄêÀ´µÄÑо¿Èȵã(Cheung A K.Transcriptionalanalysis of porcine circovirus type 2 [J]. Virology, 2003,305 168-180 £» Cheung A K.Comparative analysis of the transcriptional patterns ofpathogenic and nonpathogenic porcine circoviruses[J]. Virology, 2003,310 :41-49 £»Nawagitgul P£¬Morozov I£¬Bolin S R£¬et al. Open readingframe 2 of porcine circovirus type 2 encodes a major capsid protein[J]. Journal of General Virology£¬2000£¬81 :2281-2287 £»Liu J£¬Chen I£¬Kwang J.Characterization of a previously unidentified viral protein inporcine circovirus type 2Ò»infected cells and its role in virus-inducedapoptosis[J]. Journal of Virology,2005£¬ 79 :8262-8274 £»Liu J£¬Chen I£¬Du Q£¬et al. The 0RF3 protein of porcine circovirus type 2 is involved inviral pathogenesis in vivo[J]. Journal of Virology,2006, 80:5065-5073.)¡£ÓйØPCV2±äÒìµÄÑо¿²»¶ÏÔö¶à£¬ÊÀ½ç·¶Î§ÄÚPCV2²»¶Ï±äÒì(Wen L B£¬Guo X£¬Yang H C. Genotyping of porcine circovirus type 2from a variety of clinical conditions in china[J]. Veterinary Microbiology, 2005,110 :141-146 £»Áõ ÐÂÎÄ£¬²Üʤ²¨£¬¹ù¶«´º£¬µÈ.ÖíIIÐÍÔ²»·²¡¶¾(PCM)HenanÖêµÄ·ÖÀëÓëÈ«»ùÒò×éÐòÁÐ·Ö Îö[J]¡¤ÖйúÔ¤·ÀÊÞҽѧ±¨£¬2006, ) :357-359 £»Fenaux M, Halbur P G, Gill M, et al. Genetic characterization of type 2 porcine circovirus(PCV2)from pigswith postweaning multisystemic wasting syndrome in differentgeographic regions ofNorthern America and development of adifferential PCR-Restriction Fragment Length Polymorphism Assay todetect and differentiate between infectious with PCV-I and PCV-2[J]. Journal of Clinical Microbiology,2000,38(7) :2494-2503 £»Choi K S, Chae J S. Genetic characterization of porcine circovirus type 2 inRepublic of Korea [J]. Research in Veterinary Science, 2008,84 :497-501. )¡£Segales µÈ¶Ô²» ͬPCV2·ÖÀëÖê½øÐбê×¼ÃüÃû£¬Ö÷Òª·ÖΪPCMa¡¢PCV2bºÍPCV2cÈý¸ö»ùÒòÐÍ£¬´ËÃüÃû±ê×¼ ÓÐÀûÓÚ½ñºó¶ÔPCV2µÄÑо¿ºÍÃüÃû¹æ·¶(www.pcvd.net) (Grau R L, Crisci E, Sibila M, etal. A proposal on porcine circovirus type 2 (PCV2)genotype definitionand their relation with postweaning multisystemic wasting syndrome (PMWS) occurrence[J]. Veterinary Microbiology£¬2008£¬128 :23-35.)¡£´ËÍ⣬Yang µÈ±¨µÀÖйú³öÏÖÐ嵀 PCV2 ±ä Òì¶¾Ö꣬½«ÆäÃüÃûΪPCV2d»ùÒòÐÍ£¬ÏÔʾPCV2Á÷Ðж¾Öê²»¶Ï±äÒìÇÒÓбäÒì¶¾Öê³öÏÖ(Wang F£¬Guo X£¬Ge X N£¬et al¡¤ Genetic variation analysis of Chinese strains ofporcine circovirus type 2 [J]. Virus !Research£¬2009£¬145 :151-156.)¡£Ciacci µÈ±¨µÀÁÙ´²ÖÐ ²»Í¬»ùÒòÐÍPCV2¹²´æ£¬ÆäÓëµØÀí·Ö²¼ÎÞÏà¹ØÐÔ(Ciacci J R£¬Simon N L£¬Pinto L S£¬et al. Detection of porcineCircovirus type 2 (PCV2)variants PCV2-1 and PCV2-2 in Brazilian pigpopulation[J]. Research in Veterinary Science£¬2009£¬87 :157-160.)¡£ DupontµÈÖ¤Ã÷£¬PCV2²¡¶¾»ùÒòÐòÁÐÓëÆäÖ²¡ÐÔûÓÐÖ±½ÓÏà¹ØÐÔ£¬²¢·ÖÀëµ½»ùÒò×éΪ1766nt µÄ¶¾Öê(Dupont K, Nielsen E 0, Bakbo P, etal. Genetic analysis of PCV2 isolates from Danish archives and a currentPMWS case-control study supports a shift in genotypes with time [J]. Veterinary Microbiology, 2008£¬128 :56-64.)¡£×Ô 2003 ÄêÒÔÀ´£¬ ÊÀ½ç·¶Î§ÄÚPCV2»ùÒòÐÍ´æÔÚתÐÍÏÖÏ󣬲¢Ô¤ÑÔÐÂÐÍPCV2ÊǸüºÃµÄÊÊÓ¦ÐͶ¾Ö꣬ÆäÖ²¡ÐÔ»á ÔöÇ¿¡£GrauµÈ±¨µÀĿǰÊÀ½ç·¶Î§ÄÚPCV2Á÷ÐгÊÏÖÓÉÉ¢·¢µ½¹ã·ºÁ÷ÐÐÇ÷ÊÆ¡£Ä¿Ç°£¬PCV2Á÷ÐÐ ¶¾Öê»ùÒòÐÍ´æÔÚPCVhÏòPCV2bתÐÍÏÖÏ󣬵«»¹Ã»ÓÐÈ·ÔäÖ¤¾ÝÖ¤Ã÷¸ÃÁ½ÖÖ»ùÒòÐÍ´æÔÚDZÔÚ µÄ¶¾Á¦²îÒ죬²¢Ô¤ÑÔ½«À´ÓпÉÄܳöÏÖеıäÒì¶¾Öê(Grau RL,Fraile L,Segales J. Recent advances in the epidemiology,diagnosisand control of diseases caused by porcine circovirus type 2 [J]. TheVeterinary Journal, 2010 (in press)¡¤)¡£ÊÀ½ç·¶Î§ÄÚ PCV2 ²» ¶Ï·¢Éú±äÒ죬Öйú´æÔÚPCVh¡¢PCV2bºÍPCV2dÈýÖÖ»ùÒòÐÍÁ÷Ðж¾Ö꣬²»Í¬»ùÒòÐÍPCV2ÉúÎï Ñ§ÌØÐÔ¼°Ö²¡ÐÔ²îÒìÉÐδ¼û±¨µÀ£¬ÓбØÒª¶ÔÖйúĿǰÁ÷ÐеIJ»Í¬»ùÒòÐÍPCV2Ö²¡ÐÔ²îÒì ½øÐÐÉîÈëÑо¿¡£ ½üÄêÀ´£¬ÖйúÖíȺÖÐÒòPCV2¸ÐȾÒýÆðµÄÏà¹Ø¼²²¡ÈÕÒæÑÏÖØ£¬Æä·¢²¡ÂʺÍËÀÍö Âʲ»¶ÏÔö¼Ó£¬¸øÑøÖíÒµ´øÀ´¾Þ´óµÄ¾­¼ÃËðʧ¡£¹úÍâѧÕß¶ÔÓйØPCV2Á÷Ðж¾Öê±äÒìµÄ±¨ µÀ½Ï¶à(Fenaux M£¬Halbur P G£¬GillM, et al. Genetic characterization of type 2 porcine circovirus(PCV2)from pigs with postweaning multisystemic wasting syndrome in differentgeographic regions of Northern America and development of adifferential PCR-Restriction Fragment Length Polymorphism Assay todetect and differentiate between infectious with PCV-I and PCV-2 [J]. Journal of Clinical Microbiology,2000,38 (7) :2494-2503 £»Choi K S, Chae J S.Genetic characterization of porcine circovirus type 2 inRepublic of Korea[J]. Research in Veterinary Science£¬2008£¬84 :497-501 £»Grau R L£¬Crisci E£¬Sibila M£¬et al. Aproposal on porcinecircovirus type 2(PCV2)genotype definition and their relation withpostweaning multisystemic wasting syndrome (PMWS) occurrence[J]. Veterinary Microbiology, 2008, 128 :23-35 £»Wang F, Guo X, Ge X N, etal. Genetic variation analysis of Chinese strains of porcine circovirus type2[J]. Virus Research, 2009,145 :151-156 £»Ciacci J R, Simon N L, PintoL S, et al. Detection of porcine Circovirus type 2(PCV2)variants PCV2-1 and PCV2-2 in Brazilian pig population[J]. Research in VeterinaryScience, 2009,87 :157-160 £»Dupont K, Nielsen E 0, Bakbo P, et al. Genetic analysis of PCV2 isolates from Danish archives and a currentPMWS case-control study supports a shift in genotypes with time[J]. Veterinary Microbiology, 2008,128 :56-64.)£¬PCV2 »ùÒò×éÓÉ 1767 »ò 1768nt ×é³É£¬×î½ü·¢ ÏÖ 1766nt µÄж¾Öê(Wang F, Guo X, Ge X N, etal. Genetic variaion analysis of Chinese strains of porcine circovirus type2 [J]. Virus Research,2009,145 :151-156 £»Dupont K, Nielsen E 0, Bakbo P, et al. Genetic analysis of PCV2 isolates from Danish archivesand a current PMWS case-control study supports a shift in genotypeswith time [J], Veterinary Microbiology, 2008,128 :56-64 £»¹ùÁú¾ü£¬Â½Ô»ª£¬Î£ÑÞÎ䣬µÈ.ÎÒ¹ú ²¿·ÖµØÇøÖíÔ²»·²¡¶¾2ÐÍÒÅ´«±äÒì·ÖÎö[J].ÖйúÔ¤·ÀÊÞҽѧ±¨£¬2009,31(11) =856-859 £» »ÆÁ¢Æ½£¬Áõ³¤Ã÷£¬Î£ÑÞÎ䣬µÈ.¿¹ÖíÔ²»·²¡¶¾2ÐÍCapµ°°×ÖкͻîÐÔµ¥¿Ë¡¿¹ÌåµÄÖÆ±¸¼°¼ø ¶¨[J]¡¤ÖйúÔ¤·ÀÊÞҽѧ±¨£¬2009,31 ) :132-136.)±íÃ÷PCV2Á÷Ðж¾ÖêÔÚ²»¶Ï·¢ÉúÒÅ´«±ä Òì¡£ÖйúÖíȺÖÐPCV2Á÷Ðж¾ÖêÒ»°ãÈÏΪÒÔPCV2b»ùÒòÐÍΪÖ÷£¬Ò²¿ÉÄÜ´æÔÚPCVhºÍPCV2d »ùÒòÐÍ£¬×î½ü»¹·¢ÏÖÓÐ1766nt»ùÒòÐͺÍCapµ°°×±äÒìÖ꣬±íÃ÷ÖйúPCV2Á÷Ðж¾Öê´æÔÚ¶àÑù ÐÔÌØµã(¹ùÁú¾ü£¬Â½Ô»ª£¬Î£ÑÞÎ䣬µÈ.ÎÒ¹ú²¿·ÖµØÇøÖíÔ²»·²¡¶¾2ÐÍÒÅ´«±äÒì·ÖÎö[J].ÖÐ ¹úÔ¤·ÀÊÞҽѧ±¨£¬2009£¬31 (11) :856-859)¡£ÖíÔ²»·²¡¶¾2ÐÍ(PCV2)¸ÐȾÒýÆðµÄÏà¹Ø¼²²¡ÈÕ ÒæÑÏÖØ£¬Á÷Ðж¾Öê»ùÒò²»¶Ï·¢Éú±äÒ죬¸ù¾Ý²¡¶¾»ùÒò×é²îÒì·ÖΪPCVh¡¢PCV2bºÍPCV2cÈý¸ö »ùÒòÐÍ£¬»¹ÓÐPCV2d»ùÒòÐÍб¨µÀ£¬ÕâЩ²»Í¬»ùÒòÐÍPCV2¶¾ÖêµÄÖ²¡ÐÔ²îÒìÓдý²ûÃ÷¡£Îª ÁË̽ÌÖ²»Í¬»ùÒòÐÍPCV2¶¾ÖêµÄÖ²¡ÐÔ²îÒ죬ÐèҪͨ¹ý¸ÐȾÐÔ¿Ë¡¼¼ÊõÕü¾È¾ßÓв»Í¬»ùÒò ÐÍÌØµãµÄ´ú±íÐÔ¶¾Öê¡£

·¢Ã÷ÄÚÈÝ
±¾·¢Ã÷Ä¿µÄÖ®Ò»ÊÇÌṩÖíÔ²»·²¡¶¾2Ðͱê¼Ç¿Ë¡¶¾Öꣻ±¾·¢Ã÷Ä¿µÄÖ®¶þÊǽ«ÉÏÊöÖíÔ²»·²¡¶¾2Ðͱê¼Ç¿Ë¡¶¾ÖêÓ¦ÓÃÓÚPCV2Á÷Ðж¾Öê»ù Òò·ÖÐ͵ļø¶¨£»±¾·¢Ã÷µÄÉÏÊöÄ¿µÄÊÇͨ¹ýÒÔϼ¼Êõ·½°¸À´ÊµÏֵı¾·¢Ã÷²ÉÓøÐȾÐÔ¿Ë¡¼¼Êõ¹¹½¨Á˲»Í¬»ùÒòÐÍ´ú±íÐÔ¶¾Ö꣬¶ÔÕü¾ÈµÄ¶¾Öê½øÐÐÌå ÍâÉúÎïÑ§ÌØÐÔÊÔÑ飬±¾·¢Ã÷Ëù¹¹½¨µÄ4¸ö²»Í¬»ùÒòÐ͵ÄPCV2¸ÐȾÐÔ·Ö×Ó¿Ë¡£¬¾­×ª»¯Ï¸°û ºóÕü¾È 4 Öê¶¾Ö꣬·Ö±ðÃüÃûΪ PCVh/rCL¡¢PCV2b/rYJ¡¢PCV2b/rJF¡¢PCV2d/rBDH Öê¡£ÆäÖУ¬PCVh/rCLµÄ΢ÉúÎï±£²ØºÅÊÇCGMCC No. 4306¡£·ÖÀàÃüÃûÊÇÖíÔ²»·²¡¶¾2 ÐÍ(Porcine circovirus type 2)£»±£²ØÊ±¼äÊÇ2010Äê11ÔÂ10ÈÕ£»±£²Øµ¥Î»ÊÇÖйú΢Éú Îï¾úÖÖ±£²Ø¹ÜÀíίԱ»áÆÕͨ΢ÉúÎïÖÐÐÄ£»±£²ØµØÖ·ÊDZ±¾©Êг¯ÑôÇø±±³½Î÷·1ºÅÔº3ºÅ£¬ Öйú¿ÆÑ§ÔºÎ¢ÉúÎïÑо¿Ëù¡£
5
PCMb/rYJµÄ΢ÉúÎï±£²ØºÅÊÇCGMCC No. 4308¡£·ÖÀàÃüÃûÊÇÖíÔ²»·²¡¶¾2ÐÍ (Porcine circovirus type 2)£»±£²ØÊ±¼äÊÇ2010Äê11ÔÂ10ÈÕ£»±£²Øµ¥Î»ÊÇÖйú΢ÉúÎï ¾úÖÖ±£²Ø¹ÜÀíίԱ»áÆÕͨ΢ÉúÎïÖÐÐÄ£»±£²ØµØÖ·ÊDZ±¾©Êг¯ÑôÇø±±³½Î÷·1ºÅÔº3ºÅ£¬ÖÐ ¹ú¿ÆÑ§ÔºÎ¢ÉúÎïÑо¿Ëù¡£PCMb/rJFµÄ΢ÉúÎï±£²ØºÅÊÇCGMCC No. 4307¡£·ÖÀàÃüÃûÊÇÖíÔ²»·²¡¶¾2ÐÍ (Porcine circovirus type 2)£»±£²ØÊ±¼äÊÇ2010Äê11ÔÂ10Ä¿£»±£²Øµ¥Î»ÊÇÖйú΢ÉúÎï ¾úÖÖ±£²Ø¹ÜÀíίԱ»áÆÕͨ΢ÉúÎïÖÐÐÄ£»±£²ØµØÖ·ÊDZ±¾©Êг¯ÑôÇø±±³½Î÷·1ºÅÔº3ºÅ£¬ÖÐ ¹ú¿ÆÑ§ÔºÎ¢ÉúÎïÑо¿Ëù¡£PCV2d/rBDHÖêµÄ΢ÉúÎï±£²ØºÅÊÇCGMCC No. 4309¡£·ÖÀàÃüÃûÊÇÖíÔ²»·²¡¶¾2ÐÍ (Porcine circovirus type 2)£»±£²ØÊ±¼äÊÇ2010Äê11ÔÂ10ÈÕ£»±£²Øµ¥Î»ÊÇÖйú΢ÉúÎï ¾úÖÖ±£²Ø¹ÜÀíίԱ»áÆÕͨ΢ÉúÎïÖÐÐÄ£»±£²ØµØÖ·ÊDZ±¾©Êг¯ÑôÇø±±³½Î÷·1ºÅÔº3ºÅ£¬ÖÐ ¹ú¿ÆÑ§ÔºÎ¢ÉúÎïÑо¿Ëù¡£¾­ºËËáÐòÁзÖÎö¡¢²¡¶¾ÐÎ̬ѧ¹Û²ì¡¢ÃâÒß¹ýÑõ»¯Îïøµ¥²ãϸ°ûÊÔÑé(IPMA)µÈ֤ʵ ±¾·¢Ã÷ËùÕü¾ÈµÄ4¸ö¿Ë¡¶¾ÖêÊôÓÚ²»Í¬»ùÒòÐ͵ÄPCV2¶¾Öꣻ±¾·¢Ã÷ËùÕü¾ÈµÄ¶¾Öê¾ùͨ¹ýϸ °ûÁ¬Ðø´«10´ú£¬²¡¶¾ÔöÖ³ÄÜÁ¦Îȶ¨£¬¶¾¼Û¾ù¿É´ïµ½105 (lTCID5(l/ml £»ÓþßÓÐÖкͲ¡¶¾»îÐ﵀ µ¥¿Ë¡¿¹Ìå(1D2Öê)½øÐп¹Ô­²¶»ñELISA¼ì²â£¬Õü¾ÈµÄPCVh/rCL¶¾ÖêÓë¸Ãµ¥¿¹²úÉúÌØÒì ÐÔ·´Ó¦£¬Áí3¸ö¿Ë¡¶¾Öê(PCV2b/rYJ¡¢rJFºÍPCV2d/rBDH)Óë¸Ãµ¥¿¹¾ùÎÞ·´Ó¦£¬±íÃ÷ËüÃÇÊô ÓÚ²»Í¬»ùÒòÐÍ´ú±í¶¾Öê¡£Õâ±íÃ÷ÖйúÖíȺÖÐPCV2Á÷Ðж¾Öê´æÔÚ²»Í¬»ùÒòÐÍ£¬Æä²¡¶¾¿¹Ô­ÌØ ÐÔ¸÷Ò죬±¾·¢Ã÷Ëù¹¹½¨ºÍÕü¾ÈµÄ4¸ö´ú±í²»Í¬»ùÒòÐÍPCV2¿Ë¡¶¾Ö꣬Ϊ½øÒ»²½Ñо¿ÆäÖ²¡ ÐÔ²îÒìµì¶¨ÁË»ù´¡£¬¿É×÷ΪPCV2Á÷Ðж¾Öê»ùÒò·ÖÐ͵ļø¶¨¡£ÎªÁË̽ÌÖ²»Í¬»ùÒòÐÍPCV2¶¾ÖêµÄÖ²¡ÐÔ²îÒ죬ͨ¹ý¸ÐȾÐÔ¿Ë¡¼¼ÊõÕü¾È¾ßÓв» ͬ»ùÒòÐÍÌØµãµÄ´ú±íÐÔ¶¾Ö꣬¶Ô»ñµÃµÄ¿Ë¡²¡¶¾ÌåÍâÊÔÑé½á¹û±íÃ÷£¬ÕâЩ¶¾ÖêÔÚ¿¹Ô­ÐÔ¡¢ »ùÒò×éøÇÐλµã·Ö²¼¡¢·±Ö³¹æÂɵȶàÏîÖ¸±ê´æÔÚ²îÒ죬±íÃ÷ÖйúÖíȺÖÐÁ÷ÐÐPCV2¶¾ÖêÊ®·Ö ¸´ÔÓ£¬²»Í¬»ùÒòÐͶ¾Öê¹²´æ¡£PCV2 0RF2±àÂëCapµ°°×ÊǸò¡¶¾µÄÖ÷Òª½á¹¹µ°°×£¬Ò²ÊDz¡¶¾µÄ±£»¤ÐÔ¿¹Ô­£¬½üÄê À´£¬¸Ãµ°°×Ò²²»¶Ï·¢Éú±äÒì(¹ùÁú¾ü£¬Â½Ô»ª£¬Î£ÑÞÎ䣬µÈ.ÎÒ¹ú²¿·ÖµØÇøÖíÔ²»·²¡¶¾2ÐÍÒÅ ´«±äÒì·ÖÎö[J].ÖйúÔ¤·ÀÊÞҽѧ±¨£¬2009£¬31 (11) =856-859 £»Shang S B, Jin Y L£¬JiangX T, Zhou J Y, Zhang X, Xing G, He J L, Yan Y, Fine mapping ofantigenic epitopes on capsid proteins of porcine circovirus and antigenicphenotype of porcine circovirus type 2[J]. Molecular Immunology,2009,46 :327-334 £»Olvera A, Cortey M, Segales J. Molecular evolution ofporcine circovirus type 2 genomes :Phylogeny and clonality [J]. Virology, 2007, 357 :175-185)¡£¶Ô·ÖÀë¶¾Öê 0RF2 ÍÆµ¼µÄ°±»ùËáÐòÁÐ·Ö Îö·¢ÏÖ£¬PCV2b»ùÒòÐÍYJ¶¾ÖêºÍPCV2d¶¾Öê(BDH)ÓÉÓÚ0RF2±àÂëµ°°×ÔĶÁ¿ò¼Ü·¢Éú¸Ä±ä£¬ µ¼ÖÂCapµ°°×CÄ©¶ËÓÐ1 2¸ö°±»ùËáÑÓÉìÏÖÏó¡£ÖܼÌÓµȱ¨µÀµÄ¶¾Öê(EU257516)£¬ÓÉÓÚ »ùÒò×éµÚ1060λÓÐÒ»¸ö¼î»ùȱʧ£¬Æä0RF2»ùÒò·¢ÉúÍ»±ä£¬µ¼ÖÂÁË 0RF2±àÂëCapµ°°×CÄ© ¶ËÓÐÁ½¸ö°±»ùËá(N ºÍ E)ÑÓÉì(Shang S B£¬Jin Y L£¬Jiang X T£¬Zhou J Y£¬Zhang X£¬Xing G,He J L,Yan Y. Fine mapping of antigenic epitopes on capsidproteins of porcine circovirus and antigenic phenotype of porcinecircovirus type 2[J]. Molecular Immunology, 2009,46 :327-334)¡£±¾·¢Ã÷ͨ¹ý¸ÐȾÐÔ¿Ë¡Õü¾ÈµÄrYJÖê(1766nt)£¬ÔÚ»ùÒò×éµÚ1039λҲ·¢ÏÖÓÐÒ»¸ö¼î»ùȱʧ£¬µ¼ÖÂÁËÆä0RF2»ùÒòÔĶÁ¿ò¼Ü·¢Éú¸Ä±ä£¬ÒýÆðÁË 0RF2 ±àÂëCapµ°°×CÄ©¶ËÓÐÁ½¸ö°±»ùËá(NºÍE)ÑÓÉì¡£OlveraµÈQ007)Ñо¿Ò²Ö¤Êµ£¬0RF2ÖÕ Ö¹ÃÜÂë×Ó·¢ÉúÍ»±ä£¬»áµ¼ÖÂCapµ°°×CÄ©¶ËÓÐÒ»¸öÀµ°±Ëá(K)ÑÓÉì(Olvera A£¬Cortey M£¬ Segales J. Molecularevolution of porcine circovirus type 2 genomes :Phylogeny and clonality[J], Virology,2007,357 :175-185)¡£±¾·¢Ã÷Õü¾ÈµÄ rBDH¶¾Ö꣬ÓÉÓÚ 0RF2 ÖÕ Ö¹ÃÜÂë×Ó·¢ÉúÍ»±ä£¬µ¼ÖÂÁË Capµ°°×CÄ©¶Ë·Ö±ðÓÐÒ»¸öÀµ°±Ëá(K)µÄÑÓÉ죬ÓëÉÏÊöÑо¿±¨¸æ »ù±¾Ò»Ö¡£´ËÍ⣬KnellµÈÒѱ¨µÀ»ùÒò×é1767nt¶¾Öê(GenBankÐòÁкÅAY71!M70)£¬ÓÉÓÚ»ù Òò×éµÚ1042λÓÐÒ»¸ö¼î»ùTȱʧ£¬Æä0RF2»ùÒò·¢ÉúÍ»±ä£¬µ¼ÖÂÁË 0RF2±àÂëCapµ°°×CÄ© ¶ËÓÐÒ»¸öÀµ°±»ùËá(K)ÑÓÉì(Knell S, Willems H, Hertrampf B, Reiner G. Comparative genetic characterization of porcine circovirus type2 samples from German wild boar populations [J]. VeterinaryMicrobiology, 2005,109 :169-177.)¡£±¾·¢Ã÷Ñ¡Ôñ 4 ¸ö ²»Í¬»ùÒòÐÍPCV2Á÷Ðж¾Ö꣬ÒÔÆä0RF2ÔĶÁ¿ò¼Ü²»Í¬ÎªÄ¿±ê£¬¶Ô¼î»ùȱʧ»òÍ»±ä¿ÉÄÜ»áÒýÆð ¸Ã²¡¶¾Capµ°°×¿¹Ô­ÐÔ¡¢Ö²¡ÐÔ¼°¶¾Á¦µÄ¸Ä±ä×÷ÎªÍ»ÆÆ¿Ú£¬ÊÔͼ²ûÃ÷»ùÒòÒÅ´«±äÒì¹æÂÉÓë Ö²¡ÐԸıäÊÇ·ñ´æÔÚÏà¹ØÐÔ¡£¹ØÓÚPCV2¸ÐȾÐÔ¿Ë¡µÄ¹¹½¨¼°²¡¶¾Õü¾ÈÒÑÓв»ÉÙ±¨µÀ£¬²»Í¬·½Ê½»ñµÃµÄÕü¾È²¡ ¶¾¸÷ÓÐËù³¤(Û­öΣ¬³Â»À´º£¬³Â»ªÆ½£¬²Üʤ²¨£¬è¢´ºÃ·.ÖíIIÐÍÔ²»·²¡¶¾È«»ùÒò×éµÄ¿Ë¡¼° ¸ÐȾÐÔ¼ø¶¨[J]¡¤Î¢ÉúÎïѧ±¨£¬2004£¬44 O) :172-176.)¡£±¾·¢Ã÷²ÉÓÃKOD¸ß±£ÕæPCR·´Ó¦£¬ ʹÀ©Ôö²úÎï±£Õæ¶È½ÏÆÕͨTaqøÌá¸ßÁË 70±¶£¬ÓÐЧµØ±£Ö¤ÁËÑо¿½á¹ûµÄ¿É¿¿ÐÔ¡£ÔÚPCR ÒýÎïÉè¼ÆÉÏÒýÈëÁË Ml IÄÚÇÐøλµã£¬¿É×÷ΪÒÅ´«±ê¼ÇÎ¹¹½¨µÄ¿Ë¡¶¾ÖêÓëÒ°ÉúÐÍÇ×±¾¶¾ ÖêÏà¼ø±ð¡£±¾·¢Ã÷¹¹½¨µÄ¸ÐȾÐÔ¿Ë¡¼°Õü¾È²¡¶¾¼¼Êõ£¬¾ßÓÐÏÔÖøÓÅÊÆ£¬²Ù×÷¼ò±ã£¬Öظ´ÐԺ㬠Õü¾È²¡¶¾´øÓзÖ×Ó±ê¼Ç£¬Ò×ÓÚ¼ø±ð¡£ÓÉÓÚPCV2¸ÐȾϸ°û²»²úÉúÃ÷ÏÔϸ°û²¡±ä£¬²ÉÓ󣹿·½ ·¨·ÖÀ벡¶¾¼«Ò×ÎÛȾÍâÔ´²¡¶¾£¬Òò´Ë£¬²ÉÓøÐȾÐÔ¿Ë¡;¾¶»ñµÃ¿Ë¡¶¾ÖêÊǽâ¾öÕâÒ»ÎÊÌ⠹ؼü£¬»ñµÃµÄ¶¾Öê¸ü¼Ó´¿¾»¡£Í¨¹ý¶Ô¿Ë¡¶¾ÖêÌåÍâϸ°ûÅàÑøÌØÐÔµÄÁË½â£¬ÕÆÎÕÁ˲¡¶¾·±Ö³¹æ ÂÉ£¬Ê¹¿Ë¡¶¾ÖêÌåÍâÔöÖ³ÄÜÁ¦´ó·ùÌá¸ß¡£±¾·¢Ã÷ΪÉîÈ뿪չÖíÔ²»·²¡¶¾2Ð͵ķÖ×ÓÉúÎïѧ¡¢ Ö²¡»úÖÆ¡¢·Ö×Ó¼ø±ðÕï¶Ï¼°ÃâÒßѧµÄÑо¿¿ª±ÙÁËÐÂ;¾¶¡£


ͼIIPMA·¨¶Ô²»Í¬»ùÒòÐÍPCV2Õü¾ÈµÄ4¸ö¿Ë¡¶¾ÖêµÄ¼ø¶¨¡£Í¼2PCV2Õü¾ÈµÄ¿Ë¡²¡¶¾Á£×ÓµÄÃâÒߵ羵¹Û²ì¡£Í¼3Õü¾È²¡¶¾4ÖêPCV2»ùÒò×éPCR-RFLP¼ø¶¨½á¹û¡£Í¼4¿Ë¡µÄ4¸öPCV2¶¾Ö겻ͬ´ú´Î²¡¶¾ÌåÍâÔöÖ³ÇúÏß¡£Í¼5IPMA·½·¨¶ÔÕü¾ÈµÄPCV2¶¾Ö겻ͬʱ¼äµãÔöÖ³¹æÂɵļø¶¨¡£Í¼6¿¹Ô­²¶»ñELISA·¨¼ì²â1D2µ¥¿¹¶Ô4¸öÕü¾ÈµÄPCV2¶¾ÖêµÄ¿¹Ô­·´Ó¦»îÐÔ¡£
¾ßÌåʵʩÀý·½Ê½ÏÂÃæ½áºÏ¾ßÌåʵʩÀýÀ´½øÒ»²½ÃèÊö±¾·¢Ã÷£¬±¾·¢Ã÷µÄÓŵãºÍÌØµã½«»áËæ×ÅÃèÊö¶ø ¸üΪÇå³þ¡£µ«ÕâЩʵʩÀý½öÊÇ·¶ÀýÐԵ쬲¢²»¶Ô±¾·¢Ã÷µÄ·¶Î§¹¹³ÉÈκÎÏÞÖÆ¡£±¾ÁìÓò¼¼Êõ ÈËÔ±Ó¦¸ÃÀí½âµÄÊÇ£¬ÔÚ²»Æ«Àë±¾·¢Ã÷µÄ¾«ÉñºÍ·¶Î§Ï¿ÉÒÔ¶Ô±¾·¢Ã÷¼¼Êõ·½°¸µÄϸ½ÚºÍÐÎʽ½øÐÐÐ޸ĻòÌæ»»£¬µ«ÕâЩÐ޸ĺÍÌæ»»¾ùÂäÈë±¾·¢Ã÷µÄ±£»¤·¶Î§ÄÚ¡£ÊµÊ©Àý1²ÄÁÏÓë·½·¨1. 1ϸ°û¶¾ÖêÖÊÁ£¿¹Ìå°´ÎÄÏ×·½·¨(Áõ³¤Ã÷£¬Õų¬·¶£¬Î£ÑÞÎ䣬µÈ.ÖíÔ²»·²¡¶¾2ÐÍϸ°ûÅàÑøÊÊÓ¦¶¾ÖêµÄ ÅàÓýºÍ¼ø¶¨[J].ÖйúÔ¤·ÀÊÞҽѧ±¨£¬2006£¬›a(3) =248-252.)²ÉÓÃH(15ϸ°û(ÎÞPCVlÎÛ È¾)¶ÔÁÙ´²ËͼìµÄPCV2ÑôÐÔ²¡ÁϽøÐв¡¶¾·ÖÀëÅàÑø£¬»ñµÃPCV2/CL¡¢PCV2/YJ¡¢PCV2/JFºÍ PCV2/BDHËÄÖ겻ͬ»ùÒòÐÍPCV2ÁÙ´²Á÷Ðж¾Ö꣬ËüÃǾßÓдú±í²»Í¬»ùÒòÌØÐÔ(¹ùÁú¾ü£¬Â½ Ô»ª£¬Î£ÑÞÎ䣬µÈ.ÎÒ¹ú²¿·ÖµØÇøÖíÔ²»·²¡¶¾2ÐÍÒÅ´«±äÒì·ÖÎö[J].ÖйúÔ¤·ÀÊÞҽѧ±¨£¬ 2009,31(11) :856-859.)¡£ÖØ×é¸Ë×´²¡¶¾±í´ïµÄPCMa/LGÖêCapµ°°×µ¥¿Ë¡¿¹Ìå(mAb) 1D2 ÖÆ±¸²Î¿¼ÎÄÏ×(»ÆÁ¢Æ½£¬Áõ³¤Ã÷£¬Î£ÑÞÎ䣬µÈ.¿¹ÖíÔ²»·²¡¶¾2ÐÍCapµ°°×ÖкͻîÐÔµ¥¿Ë¡ ¿¹ÌåµÄÖÆ±¸¼°¼ø¶¨[J]¡¤ÖйúÔ¤·ÀÊÞҽѧ±¨£¬2009,31 ) :132-136) 01. 2 ÊÔÆë[JKOD-Plus-¸ß±£ÕæPCRÀ©ÔöÊÔ¼ÁºÐΪ"Toyobo²úÆ·£»ÏÞÖÆÐÔÄÚÇÐø¡¢pMD18_TÔØÌ幺 ×ÔTaKaRa²úÆ·£¬Lipofectamine 2000¹º×ÔInvitrogen£¬T0P10¸ÐÊÜ̬¾ú¹º×ÔÌì¸ù¹«Ë¾£¬ÖÊ Á£ÌáÈ¡ÊÔ¼ÁºÐ¹º×ÔQIAGEN¹«Ë¾¡£1. 3ÒýÎïÉè¼ÆºÍPCRÀ©Ôö²Î¿¼GenBank AF201311ÐòÁÐÉè¼ÆÒýÎÉÏÓÎÒýÎïΪPCV2-F£¬ÏÂÓÎÒýÎïΪPCV2-R£¬ ÓÉTaKaRa¹«Ë¾ºÏ³É¡£ÐòÁÐÈçÏÂPCV2-F 5' -GTCGACGGAGGAAGGGGGCCAGTT-3¡®£»PCV2-R 5' -GTCGACTGTTCTGTAGCATTCTTCCA-3¡®(Ï»®Ïß´¦ÎªI øÇÐλµã)¡£PCV2È«³¤À©ÔöµÄPCR·´Ó¦ÌåϵÈçÏÂPCV2¼ì²âÓõÄÉÏÏÂÓι­Ø­ÎïPCV2-F/ PCV2-R(20y M)¸÷ 0. 5 ¦Ì 1£¬10XKOD Buffer 2. 5 ¦Ì 1,2. 5mM dNTP 2. 5 ¦Ì l,25mM MgS04 1 ¦Ì 1£¬K0D¸ß±£ÕæDNA¾ÛºÏø0. 5U£¬°´´«Í³·½·¨ÌáÈ¡µÄ²¡¶¾ºËËá2. 5 ¦Ì 1£¬¼ÓÈëÃð¾úË«ÕôË®ÖÁ 25 ¦Ì 1¡£PCR ·´Ó¦Ìõ¼þΪԤ±äÐÔ 94¡ãC 5min £»£»35 ¸öÑ­»·£¬94¡ãC 20s, 62¡ãC 30s, 68¡ãC 2min£¬×îºó 68¡ãCÑÓÉìlOmin¡£PCR²úÎï¾­1 %ÇíÖ¬ÌÇÄý½ºµçÓ¾·ÖÎö¼ø¶¨¡£1. 4²¡¶¾»ùÒò×é¿Ë¡¼°ÖØ×éÖÊÁ£¼ø¶¨°´ÕÕDNA½º»ØÊÕÊÔ¼ÁºÐµÄ²½Öè¶ÔPCR²úÎï½øÐлØÊÕ£¬È¡»ØÊÕ²úÎïÓëpMD18_TÔØÌå Á¬½Ó£¬Á¬½Ó·´Ó¦ÌåϵΪ4¦Ì 1»ØÊÕµÄPCR²úÎ5 ¦Ì 1 Solution ¦©£¬1¦Ì1 pMD18_TÔØÌ壬16¡ãC Á¬½Ó¹ýÒ¹£¬È»ºóת»¯T0P10¸ÐÊÜ̬ϸ°û£¬ÔÚIPTG¡¢X-galÓÕµ¼ÏÂ37¡ãCÅàÑø1 16h£¬ÌôÈ¡5 ¸ö°×°ß¾úÂä½ÓÖÖLBÒºÌåÅàÑø»ù£¬ÅàÑø¹ýÒ¹ºó°´ÖÊÁ£ÌáÈ¡ÊÔ¼ÁºÐµÄ²½ÖèÌáÈ¡ÖÊÁ££¬ÖÊÁ£ÓÃÄÚ ÇÐøMl I½øÐÐÑôÐÔÖØ×é×ӵĸÇмø¶¨¡£Í¬Ê±Ã¿¸öÁ÷Ðж¾Öêѡȡ3¸öÉÏÊö¾­Ã¸Çмø¶¨µÄ ÑôÐÔ¿Ë¡ËÍÉϺ£Éú¹¤ÉúÎï¼¼Êõ·þÎñÓÐÏÞ¹«Ë¾½øÐÐÐòÁвⶨ¡£1. 5²¡¶¾»ùÒò×é»·»¯¼°DNAתȾϸ°û¾­²âÐòÓ¡Ö¤ºÍøÇмø¶¨ºó£¬½«ÑôÐÔת»¯¾ú½øÐÐÀ©´óÅàÑø²¢ÌáÈ¡ÖÊÁ££¬²¢¶ÔÌáÈ¡ÖÊ Á£½øÐÐMl IøÇС£¶ÔøÇнº»ØÊÕ²úÎïÓÃT4 DNA¾ÛºÏø½øÐл·»¯£¬»·»¯ÌåϵΪ20¦Ì1£¬ÆäÖÐ IOXT4 DNA Iigationbuffer 2¦Ì 1, T4 DNA Iigase 2 ¦Ì 1£¬½º»ØÊÕ²úÎï 16 ¦Ì 1£¬16¡ãC£¬30min¡£ ½«»·»¯µÄDNA°´ÕÕתȾÊÔ¼ÁºÐ³ÌÐò½øÐÐH(15ϸ°ûתȾÊÔÑé¡£1. 6¿Ë¡¶¾ÖêµÄÕü¾È¼°ÃâÒßѧ¼ø¶¨
¶ÔÕü¾ÈµÄ¸ÐȾÐÔ¿Ë¡¶¾Ö꣬°´³£¹æ·½·¨½øÐв¡¶¾Ï¸°û´«´ú£¬È¡µÚ4´ú²¡¶¾ÒºÍ¬²½ ½ÓÖÖH(15ϸ°ûÓÚ96¿×°åÄÚ£¬²¡¶¾¸ÐȾϸ°û72h¹Ì¶¨Ï¸°û£¬ÓÃPCV2ÑôÐÔѪÇå½øÐÐIPMA·¨¼ì ²â¿Ë¡¶¾ÖêµÄÃâÒßѧ·´Ó¦Çé¿ö¡£1. 7¿Ë¡¶¾Öêµç¾µÐÎ̬ѧ¹Û²ìÈ¡¿Ë¡¶¾ÖêµÚ10´úϸ°ûÅàÑøÎ·´¸´¶³ÈÚ3´Î£¬È¡3ml²¡¶¾Òº£¬12£¬000r/minÀë ÐÄ30min£¬Ð¡ÐÄÎüÈ¡ÉÏÇ壬°´1 %Ìå»ý¼ÓÈëPCV2ÑôÐÔѪÇ忹Ìå»ì„ò£¬ÖÃ4¡ãC¹ýÒ¹£¬È»ºó½øÐÐ 12£¬000r/minÀëÐÄ30min£¬ÆúµôÉÏÇ壬ÓÃ50 ¦Ì 1 PBSÒº(¦Ñ¦§7. 4)Èܽâ³Áµí£¬È¡Ñù½øÐÐ2%Á×ÎÙ ËḺȾ£¬µç¾µ¹Û²ì²¡¶¾Á£×ÓÐγɵÄÃâÒ߸´ºÏÎï¡£1. 8¿Ë¡¶¾Öê»ùÒò×é²âÐò¼°PCR-RFLP·ÖÎö°´1. 3ºÍ1. 4Ïî¶ÔÕü¾È²¡¶¾»ùÒò×éÀ©Ôö²¢½øÐÐÐòÁвⶨ£¬Ñ¡ÓÃ!^ba IºÍAcc IÏÞ ÖÆÐÔÄÚÇÐø·Ö±ð¶ÔÕü¾ÈµÄ4Öê¶¾Öê»ùÒò×éPCRÀ©Ôö²úÎï½øÐÐøÇмø¶¨(PCR-RFLP)¡£1. 9¿Ë¡¶¾Öêϸ°û´«´ú¶¾¼Û²â¶¨²ÉÓÃIPMA·¨(Áõ³¤Ã÷£¬Õų¬·¶£¬Î£ÑÞÎ䣬µÈ.ÖíÔ²»·²¡¶¾2ÐÍÃâÒß¹ýÑõ»¯Îïøµ¥²ã ϸ°ûÊÔÑ鿹Ìå¼ì²âÊÔ¼ÁºÐµÄÑÐÖÆ¼°Ó¦ÓÃ[J].ÖйúÔ¤·ÀÊÞҽѧ±¨£¬2007£¬ËÄ(8) :621-624.) ¶Ô4Öê¿Ë¡²¡¶¾ÖêµÄ²»Í¬´ú´Î½øÐж¾¼Û²â¶¨£¬¼ÆË㲡¶¾°ëÊýϸ°û¸ÐȾÁ¿(TCID5(l/ml)£¬²â¶¨ ²»Í¬»ùÒòÐÍPCV2¶¾ÖêÌåÍâϸ°ûÔöÖ³¹æÂÉ¡£1. 10¿Ë¡¶¾Öê¸ÐȾϸ°û¶¯Á¦Ñ§²â¶¨È¡¿Ë¡¶¾ÖêµÄµÚ10´úϸ°ûÅàÑøÎͬ²½½ÓÖÖÐÂÏû»¯µÄHQ5ϸ°ûÓÚ96¿×ϸ°ûÅàÑø °å£¬Í¬ÉèPCV2/LG²Î¿¼ÖêΪÑôÐÔ¶ÔÕÕºÍδ½ÓÖÖ²¡¶¾Ï¸°ûΪÒõÐÔ¶ÔÕÕ¡£²¡¶¾½ÓÖÖºó12h¡¢Mh¡¢ 48h¡¢60h¡¢72h¡¢84h¡¢£¥h²»Í¬Ê±¼äµã¹Ì¶¨Ï¸°û£¬²ÉÓÃIPMA·¨¼ì²â²¡¶¾¸ÐȾϸ°û¶¯Á¦Ñ§ÔöÖ³¹æÂÉ¡£1. 11¿Ë¡¶¾Ö꿹ԭÐÔ²îÒì¼ø¶¨²ÉÓÃÖØ×é¸Ë×´²¡¶¾±í´ïµÄPCVh/LGÖêCapµ°°×ÖÆ±¸µÄ¾ßÓÐÖкͿ¹Ìå»îÐԵĵ¥¿Ë ¡¿¹Ìå(1D2Öê)(»ÆÁ¢Æ½£¬Áõ³¤Ã÷£¬Î£ÑÞÎ䣬µÈ.¿¹ÖíÔ²»·²¡¶¾2ÐÍCapµ°°×ÖкͻîÐÔµ¥¿Ë ¡¿¹ÌåµÄÖÆ±¸¼°¼ø¶¨[J].ÖйúÔ¤·ÀÊÞҽѧ±¨£¬2009,31 ) :132-136)½¨Á¢ÁËÒ»ÖÖ¿¹Ô­²¶»ñ ELISA·½·¨ÓÃÓÚ¼ì²âϸ°ûÅàÑøÎïÖеIJ¡¶¾¿¹Ô­¡£²ÉÓø÷½·¨·Ö±ð¶Ô¿Ë¡¶¾ÖêµÚ10´úϸ°ûÅà ÑøÎï½øÐÐÁ˼ì²â£¬¼ø¶¨Õü¾ÈµÄ²»Í¬»ùÒòÐÍPCV2¶¾Ö꿹ԭÐÔ²îÒì¡£2ÊÔÑé½á¹û2. 1²¡¶¾¸ÐȾÐÔ¿Ë¡µÄ¹¹½¨²ÉÓø߱£ÕæDNA¾ÛºÏøPCR·¨¶ÔÀ´×ÔÁÙ´²²¡ÁϽøÐÐPCV2»ùÒò×éÀ©Ôö£¬»ñµÃ4Ö겡 ¶¾È«»ùÒòPCR²úÎ½«Æä·Ö±ð¿Ë¡ÖÁpMDIS-TÔØÌåÉÏ£¬»ñµÃµÄ4ÖêÖØ×鲡¶¾È«»ùÒò×é¿Ë¡ (PMD18-PCV2-CL¡¢pMD18_PCV2_YJ¡¢pMD18_PCV2_JF ºÍ pMD18-PCV2_BDH)£¬¾­ºËËáÐòÁзÖÎöÖ¤ Ã÷£¬´ú±íÁ˲»Í¬»ùÒòÐÍPCV2¶¾Öê(PCMa¡¢PCV2bºÍPCV2d)£¬Ïê¼û±í1¡£±í1²»Í¬»ùÒòÐÍPCV2ϸ°û·ÖÀëÇ×±¾ÖêÉúÎïÑ§ÌØÐÔ
9Ç×±¾¶¾ÁÖÃû³Æ
씀PCV2/CLPCV2/YJPCV2/JFPCV2/BDH»ùÒòÐÍPCV2aPCV2bPCV2bPCV2d·ÖÀëʱ¼ä2008200820082008»ùÒò×é´óС17681766176717670RF2´óС702708702705ORFl´óС945945945945GenBankµÇ¼ºÅHM038033HM038032HM038022HM038017Óë1D2µ¥¿¹·´Ó¦ÐÔYesNoNoNo2. 2²¡¶¾µÄÕü¾È¼°¼ø¶¨¶Ô4ÖêÕü¾ÈµÄ²¡¶¾½øÐÐϸ°û´«´ú£¬È¡¸÷×ÔµÚ4´úÅàÑøÎïÓÃÖí¿¹PCV2¸ßÃâѪÇå½øÐÐ IPMA¼ø¶¨£¬½á¹ûÏÔʾ£¬Õü¾ÈµÄ4¸ö¶¾Öê¾ù³ÊÑôÐÔ·´Ó¦£¬Õü¾ÈµÄ4Ö겡¶¾¾ù»ñµÃ³É¹¦£¬·Ö±ðÃüÃû Ϊ PCV2a/rCL, PCV2b/rYJ, PCV2b/rJF, PCV2d/rBDH Öê(ͼ 1)¡£2. 3¿Ë¡¶¾ÖêÃâÒߵ羵¹Û²ì¶Ô4ÖêÕü¾ÈµÄ²¡¶¾Ï¸°ûÅàÑøÎï½øÐÐÃâÒߵ羵¹Û²ì£¬¸÷×ÔÑùÆ·¾ùÓв¡¶¾Á£×Ó´æÔÚ£¬ Á£×ÓÖ±¾¶Ô¼17nm£¬ÓëPCV2²¡¶¾Á£×ÓÐÎ̬һÖ£¬Ö¤Ã÷Õü¾ÈµÄ²¡¶¾ÊôÓÚPCV2£¬Èçͼ2Ëùʾ¡£2. 4¿Ë¡¶¾Öê»ùÒò×é²âÐò¼°PCR-RFLP·ÖÎö¾­²âÐò½á¹û±íÃ÷£¬»ñµÃµÄ4ÖêÕü¾È²¡¶¾Öê»ùÒò×éÐòÁÐÓëÇ×±¾¶¾ÖêÐòÁÐÒ»Ö£¬±íÃ÷ ͨ¹ý¸ÐȾÐÔ·Ö×Ó¿Ë¡Õü¾ÈµÄ4Ö겻ͬ»ùÒòÐÍPCV2»ñµÃ³É¹¦¡£È»ºó£¬Ñ¡ÓÃAcc IºÍ!^ba IÄÚ ÇÐø·Ö±ð¶Ô4ÖêPCV2Õü¾È¶¾Öê»ùÒò×éµÄPCRÀ©Ôö²úÎï½øÐÐÁËøÇмø¶¨£¬½á¹û±íÃ÷£¬ÓÃAcc IøÇз´Ó¦¿É½«Õâ4Ö겡¶¾·ÖΪ3ÖÖ»ùÒòÐÍ£¬ÒÀ´ÎΪPCVh/rCL¡¢PCV2b/rJF¡¢PCV2b/rYJºÍ PCV2d/rBDH(ͼ3A)¡£ÓÃ!^ba IøÇмø¶¨£¬¿É½«Õâ4Ö겡¶¾ÖеÄPCV2b(rJF¡¢rYJ)»ùÒòÐÍÖÐ 2¸ö¶¾Öê½øÐÐÇø·Ö(ͼ:3B)¡£»ùÓÚÉÏÊö2ÖÖÏÞÖÆÐÔÄÚÇÐø·´Ó¦½¨Á¢ÁË PCR-RFLP·½·¨£¬¿É×÷ ΪPCV2Á÷Ðж¾Öê»ùÒò·ÖÐͼø¶¨¡£2. 5¿Ë¡¶¾ÖêÌåÍâϸ°û´«´ú¶¾¼Û²â¶¨¶ÔÕü¾ÈµÄ4¸ö²¡¶¾ÖêµÄ²»Í¬´ú´Îϸ°ûÅàÑøÎï½øÐÐÁ˶¾¼Û²â¶¨£¬½á¹û±íÃ÷£¬Õü¾ÈµÄ ²¡¶¾ÖêÓÚ1¡¢2´úÔöÖ³±È½Ï»ºÂý£¬×ÔµÚ3´úÆð²¡¶¾ÔöÖ³¼Ó¿ì£¬ÓÚµÚ8¡¢9´úʱ¶¾¼Û»ù±¾Îȶ¨£¬¿É ´ïµ½105 0TCID50/mlÒÔÉÏ£¬½á¹û¼ûͼ4¡£2. 6¿Ë¡¶¾Öê¸ÐȾϸ°û¶¯Á¦Ñ§²â¶¨¶Ô¿Ë¡µÄ4¸ö²»Í¬»ùÒòÐÍPCV2¶¾Ö겻ͬʱ¼äµã·±Ö³¹æÂɵIJⶨ£¬½á¹û±íÃ÷£¬24h¿ª ʼ³öÏÖÃ÷ÏԵIJ¡¶¾¸ÐȾÑôÐÔϸ°û£¬µÚ72hʱ²¡¶¾ÔöÖ³´ï¸ß·å£¬Ö®ºóÓÉÓÚ²¡¶¾·±Ö³Á¿½Ï´ó£¬Òý Æð²¿·Öϸ°ûÁѽ⣬ÊͷŵIJ¡¶¾¸ÐȾÖÜΧϸ°û£¬²¡¶¾¸ÐȾÑôÐÔϸ°û³ÊÀ©É¢ÐÔ·Ö²¼£¬¼ûͼ5¡£
ȨÀûÒªÇó
1.ÖíÔ²»·²¡¶¾2Ðͱê¼Ç¿Ë¡¶¾ÖêPCV2a/rCL£¬Æä΢ÉúÎï±£²ØºÅÊÇCGMCCNo. 4306¡£
2.ÖíÔ²»·²¡¶¾2Ðͱê¼Ç¿Ë¡¶¾ÖêPCV2b/rYJ£¬Æä΢ÉúÎï±£²ØºÅÊÇCGMCCNo. 4307¡£
3.ÖíÔ²»·²¡¶¾2Ðͱê¼Ç¿Ë¡¶¾ÖêPCV2b/rJF£¬Æä΢ÉúÎï±£²ØºÅÊÇCGMCCNo. 4308¡£
4.ÖíÔ²»·²¡¶¾2Ðͱê¼Ç¿Ë¡¶¾ÖêPCV2d/rBDHÖ꣬Æä΢ÉúÎï±£²ØºÅÊÇCGMCCNo. 4309¡£
5.ȨÀûÒªÇó1-4ÈκÎÒ»ÏîËùÊöµÄÖíÔ²»·²¡¶¾2Ðͱê¼Ç¿Ë¡¶¾ÖêÔÚÖÆ±¸¼ø±ðÖíÔ²»·²¡¶¾ 2ÐͶ¾ÖêµÄÊÔ¼ÁÖеÄÓÃ;¡£
6.ȨÀûÒªÇó1-4ÈκÎÒ»ÏîËùÊöµÄÖíÔ²»·²¡¶¾2Ðͱê¼Ç¿Ë¡¶¾ÖêÔÚÖÆ±¸Ô¤·À»òÖÎÁÆÓÉÖí Ô²»·²¡¶¾2ÐÍËùÒýÆðµÄ¼²²¡µÄÒ©ÎïÖеÄÓÃ;¡£
È«ÎÄÕªÒª
±¾·¢Ã÷¹«¿ªÁËÖíÔ²»·²¡¶¾2Ðͱê¼Ç¶¾Öê¼°Æä¹¹½¨¼°ÆäÓ¦Óᣱ¾·¢Ã÷¹¹½¨ÁË4¸öPCV2²»Í¬»ùÒòÑÇÐ͵ĸÐȾÐÔ·Ö×Ó¿Ë¡£¬¾­×ª»¯Ï¸°ûºóÕü¾È4Öê¶¾Ö꣬Æä΢ÉúÎï±£²ØºÅ·Ö±ðÊÇCGMCC No.4306¡¢CGMCCNo.4307¡¢CGMCC No.4308ºÍCGMCC No.4309¡£±¾·¢Ã÷ËùÕü¾ÈµÄ4¸ö¿Ë¡¶¾ÖêÊôÓÚ²»Í¬»ùÒòÐ͵ÄPCV2¶¾Ö꣬ËùÕü¾ÈµÄ¶¾Öê¾ùͨ¹ýϸ°ûÁ¬Ðø´«10´ú£¬²¡¶¾ÔöÖ³ÄÜÁ¦Îȶ¨£¬¶¾¼Û¾ù¿É´ïµ½105.0TCID50/ml£»±¾·¢Ã÷Ëù¹¹½¨ºÍÕü¾ÈµÄ4¸ö´ú±í²»Í¬»ùÒòÐÍPCV2¿Ë¡¶¾ÖêΪ½øÒ»²½Ñо¿ÆäÖ²¡ÐÔ²îÒìµì¶¨ÁË»ù´¡£¬¿É×÷ΪPCV2Á÷Ðж¾Öê»ùÒò·ÖÐ͵ļø¶¨¡£
Îĵµ±àºÅG01N33/569GK102120987SQ201010591968
¹«¿ªÈÕ2011Äê7ÔÂ13ÈÕ ÉêÇëÈÕÆÚ2010Äê12ÔÂ10ÈÕ ÓÅÏÈȨÈÕ2010Äê12ÔÂ10ÈÕ
·¢Ã÷ÕßÁõ³¤Ã÷, ΣÑÞÎä, ¹ùÁú¾ü, ½Ô»ª ÉêÇëÈË:Öйúũҵ¿ÆÑ§Ôº¹þ¶û±õÊÞÒ½Ñо¿Ëù

  • רÀûÃû³Æ£ºÁ¬ÐøÍË»ð¯ÄÚ¯¹õ¹õÐεÄÄ£ÄâÊÔÑé×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Â¯¹õ¹õÐÎÄ£ÄâÊÔÑé×°Öã¬ÓÈÆäÉæ¼°Á¬ÐøÍË»ð¯ÄÚ¯¹õ¹õÐÎµÄ Ä£ÄâÊÔÑé×°Öᣱ³¾°¼¼Êõ£ºÔÚÁ¬ÐøÍË»ð¯ÄÚ£¬ÀäÔþºóµÄ¸Ö´ø¾­¹ý¼ÓÈȺÍÀäÈ´µÈ¸÷ÈÈ´¦Àí¹¤ÒÕ´¦Àíºó£¬²ÅÄÜ´ï µ½Óû§ËùÐèÒª
  • רÀûÃû³Æ£ºÒ»ÖÖ·ÀˤÌåμƵÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖÌåμƣ¬ÌرðÉæ¼°Ò»ÖÖ·ÀˤÌåμÆ¡£±³¾°¼¼Êõ£ºÄ¿Ç°ËùʹÓõÄÌåμÆÔÚʹÓÃʱÍâΧûÓб£»¤Íâ¿Ç£¬·ÅÔÚ×ÀÃæÉÏ»á¹ö¶¯ÈÝÒ×ˤÂ䣬ˤÂäºó»áˤËéµ¼ÖÂÌåμÆÎÞ·¨¼ÌÐøÊ¹Ó㬴ӶøÔì³ÉÀË·Ñ£¬Ä¿Ç°»¹Ã»ÓÐÓÐЧ´ë
  • רÀûÃû³Æ£ºÎ¶ÈÔÚÏß¼à²âϵͳµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Î¶ȼà²â×°Öã¬ÓÈÆäÊÇÒ»ÖÖÓÃÓÚʵʱ¼à²âµçÁ¦É豸ζȵÄÔÚÏß ¼à²âϵͳ¡£±³¾°¼¼Êõ£ºµçÁ¦ÏµÍ³µÄÐí¶àµçÆøÉ豸³¤ÆÚ´¦Ôڸߵçѹ¡¢´óµçÁ÷ºÍÂú¸ººÉÏÂÔËÐУ¬ÓÉÓÚ²ÉÓà ·â±Õʽ½á¹¹£¬É¢ÈÈЧ¹û²î£¬Æä½á¹ûÔì³É
  • רÀûÃû³Æ£ºÈ·¶¨º½¿ÕÆ÷µÄ²â¾àÐÅÏ¢µÄ²â¾àϵͳµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°ÓÃÓÚÈ·¶¨²â¾àÐÅÏ¢µÄ²â¾àϵͳºÍ²â¾à·½·¨£¬ËùÊöº½¿ÕÆ÷Я´øÍ¨ÐÅÐŵÀµÄ²¿¼þ¡£¶øÇÒ£¬±¾·¢Ã÷Éæ¼°Ò»ÖÖ½ÓÊÕÕ¾ºÍÒ»ÖÖ²Ù×÷½ÓÊÕÕ¾µÄ·½·¨¡¢Ò»ÖÖ´¦ÀíÕ¾ºÍÒ»ÖÖ´¦Àí·½·¨¡¢Ò»ÖÖº½¿ÕÆ÷ºÍÒ»ÖÖ²Ù×÷º½¿ÕÆ÷
  • רÀûÃû³Æ£º¾ßÓÐÆ¤´øÎ¶ȼì²â»ú¹¹µÄµç×ÓÆ¤´ø³ÓµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÊǹØÓÚÒ»ÖÖµç×ÓÆ¤´ø³Ó£¬ÓÈÆäÊÇÒ»ÖÖ¸ù¾ÝƤ´øÎ¶ȵı仯ÄܶԲâÁ¿¾«¶È½øÐÐʵʱ²¹³¥µÄ¾ßÓÐÆ¤´øÎ¶ȼì²â»ú¹¹µÄµç×ÓÆ¤´ø³Ó¡£±³¾°¼¼Êõ£ºµç×ÓÆ¤´ø³ÓÊÇÓÃÓÚÉú²úÏßÉÏ£¬¶Ô¹ÌÌ塢ɢËéµÄÎïÁϵÄÁ÷
  • רÀûÃû³Æ£ºÒ»ÖÖ»ùÓÚ¹âÏ˲¼À­¸ñ¹âÕ¤µÄÉù·¢ÉäÐźŴ«¸ÐϵͳµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°Ò»ÖÖ»ùÓÚ¹âÏ˲¼À­¸ñ¹âÕ¤µÄÉù·¢ÉäÐźŴ«¸Ðϵͳ£¬ÊôÓÚÉù·¢Éä¼ì²â¼¼ÊõÁìÓò¡£±³¾°¼¼Êõ£ºº½¿Õ·ÉÐÐÆ÷×÷Ϊ¹ú¼Ò×ÛºÏʵÁ¦ºÍ¾üÊÂʵÁ¦µÄÌåÏÖ£¬ÔÚÏÖ´úÕ½ÕùÖеĵØÎ»Ô½À´Ô½ÖØÒª£¬ËüÔÚÔ¤
ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾
È«¹ú·þÎñÈÈÏߣº13062023238
µç»°£º13062023238
µØÖ·£ºëøÖÝÊÐÁúȪ¹¤ÒµÔ°68ºÅ
¹Ø¼ü´Ê£ºÏ³´²£¬Êý¿ØÏ³´²£¬ÁúÃÅϳ´²
¹«Ë¾¶þάÂë
Copyright 2010-2024 °æÈ¨ËùÓÐ All rights reserved ³ICP±¸19044495ºÅ-12
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿